Reed Jobs would rather talk about curing cancer than his last name
Reed Jobs, son of Steve Jobs, is focusing on his oncology-focused venture firm, Yosemite, which aims to accelerate drug discovery through AI and philanthropy. He prefers to discuss his work in biotech rather than his family legacy.
Why it matters
The intersection of AI and drug discovery represents a major trend in venture capital and medical research, potentially shortening the timeline for cancer treatments.
Reed Jobs is easy to like. He’s motormouthed, self-deprecating, prone to video-game analogies, and clearly loves his work. He doesn’t particularly want to discuss the fact that he is Steve Jobs’s son, but he’s not uptight about it, either. When our producer, Maggie, asked if he was on a MacBook for our video call Thursday morning, he didn’t miss a beat: “Are you kidding?”
The article is a profile piece that focuses on the subject's professional endeavors and industry trends.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in